Alzheimer's disease and related dementias

There are 453 papers on Alzheimer's disease and related dementias in aging research: 24 trials and 310 observational studies in people, 5 in animals, 64 reviews. The newest story, Nov 17, 2026: “Brain surface area adds to dementia risk prediction”.

Disease

453 papers study it515 more mention it252 findings

29 new papers in 30 daysSee all 968 papers on Alzheimer's disease and related dementias

“Higher scores on neighborhood and built environment were also associated with lower ADRD risk (HRs.69 to.70).”
TESTING THE EFFECTS OF COGNITIVE TRAINING ON ALZHEIMER’S DISEASE AND RELATED DEMENTIAS: THE MODERATING ROLE OF SDOHGSA 2024 abstract2024doi:10.1093/geroni/igae098.2187
  • Human trial24
  • Humans310
  • Animals5
  • In silico25

Interventions

10

Cognitive training

downin humans2

2 studies
  1. Cognitive training protects against Alzheimer's disease and related dementias in humans (higher scores for domains associated with health care access).

    “Participants obtained a greater degree of protection from ADRD through cognitive training when they had higher scores for domains associated with health care access (HRs.68 to.75)”

    Human trialhigher scores for domains associated with health care accessn = 2,802

    TESTING THE EFFECTS OF COGNITIVE TRAINING ON ALZHEIMER’S DISEASE AND RELATED DEMENTIAS: THE MODERATING ROLE OF SDOH

    GSA 2024 abstract

  2. Cognitive training protects against Alzheimer's disease and related dementias in humans (higher scores for SDoH domains associated with health care and education access).

    “Trained participants obtained a greater degree of protection from ADRD when they had higher scores for SDoH domains associated with health care and education access.”

    Human trialhigher scores for SDoH domains associated with health care and education access20-year follow-upn = 1,605

    Effects of Cognitive Training on Alzheimer's Disease and Related Dementias: The Moderating Role of Social Determinants of Health

    Journal of aging and health

More on Cognitive training

Anthracycline plus taxane

no changein humans1

1 study
  1. Anthracycline plus taxane was not clearly linked with Alzheimer's disease and related dementias in humans (HR+/HER2- early-stage HBC, neoadjuvant setting) (RD -6.91% (95% CI: -15.60% to 0.91%)).

    “For ADRD outcome, the 10-year risk difference (RD) was -6.91% (95% CI: -15.60% to 0.91%) for HR+/HER2- cohort and -2.14% (95% CI: -9.57% to 5.46%) for TNBC cohort in Trial #1.”

    HumansHR+/HER2- early-stage HBC, neoadjuvant settingfemales

    Dementias in Older Women With Early-Stage HER2-Negative Breast Cancer Treated With Anthracycline Plus Taxane Versus Taxane-Based Chemotherapy Regimens

    Pharmacoepidemiology and drug safety

More on Anthracycline plus taxane

Annual wellness visit

no changein humans1

1 study
  1. Annual wellness visit was not clearly linked with Alzheimer's disease and related dementias in humans (fee-for-service Medicare enrollees).

    “AWV receipt was not associated with an increase in ADRD diagnosis.”

    Humansfee-for-service Medicare enrollees

    Association Between Annual Wellness Visits and Early Dementia Diagnoses: Roles of Post-Visit Healthcare Decisions

    Journal of the American Geriatrics Society

More on Annual wellness visit

Speed of processing training

no changein humans1HR 1.01

1 study
  1. Speed of processing training showed no clear effect on Alzheimer's disease and related dementias in humans (no booster training) (HR: 1.01, 95% CI: 0.81, 1.27).

    “speed-trained participants with no booster training did not have a lower risk of diagnosed ADRD (HR: 1.01, 95% CI: 0.81, 1.27)”

    Human trialno booster training20 yearsn = 2,021

    Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study

    Alzheimer's & dementia (New York, N. Y.)

More on Speed of processing training

Spatial social polarization

no changein humans1

1 study
  1. Spatial social polarization was not clearly linked with Alzheimer's disease and related dementias in humans (primarily spoken language).

    “the association with SSP in primarily spoken language was not significant”

    Humansprimarily spoken language

    Estimating the Impact of Spatial Social Polarization on Dementia Disparities

    GSA 2025 abstract

More on Spatial social polarization

Dulaglutide

no changein humans1

1 study
  1. Dulaglutide was not clearly linked with Alzheimer's disease and related dementias in humans (compared with liraglutide, in veterans with type 2 diabetes on metformin).

    “Dulaglutide had similar risk of AD/ADRD to liraglutide, however death benefit was not seen.”

    Humanscompared with liraglutide, in veterans with type 2 diabetes on metforminn = 21,173

    Risk of Alzheimer's Disease and Alzheimer's Disease‐Related Dementias with liraglutide compared to semaglutide and dulaglutide in veterans with type 2 diabetes: An emulated clinical trial observational study

    AAIC 2025 abstract

More on Dulaglutide

Occupational hazard exposure

no changein humans1

1 study
  1. Occupational hazard exposure was not clearly linked with Alzheimer's disease and related dementias in humans.

    “No statistically significant relationships between occupational exposure and ADRD were identified”

    Humans

    EDUCATION, OCCUPATIONAL ENVIRONMENT, AND COGNITIVE DECLINE IN LATE ADULTHOOD

    GSA 2024 abstract

More on Occupational hazard exposure

Park cover

no changein humans1

1 study
  1. Park cover was not clearly linked with Alzheimer's disease and related dementias in humans.

    “We found no evidence of an association of percentage park and blue space cover with ADRD hospitalization.”

    Humans

    Associations of Greenness, Parks, and Blue Space With Neurodegenerative Disease Hospitalizations Among Older US Adults

    JAMA network open

More on Park cover

Antihypertensives

no changein humans1

1 study
  1. Antihypertensives were not clearly linked with Alzheimer's disease and related dementias in humans (monotherapy vs polytherapy in older adults with hypertension).

    “We found no significant difference between monotherapy and polytherapy on the odds of ADRD diagnosis.”

    Humansmonotherapy vs polytherapy in older adults with hypertensionn = 539

    Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA

    Drugs & aging

More on Antihypertensives

COVID-19 pandemic

downin humans1

1 study
  1. COVID-19 pandemic is linked with lower Alzheimer's disease and related dementias in 2020 compared to 2017-2019 (1.30% vs. 1.40%).

    “Compared to overall annual incidence rates for ADRD codes in 2017-2019, 2020 incidence was slightly lower (1.30% vs. 1.40%)”

    Humansin 2020 compared to 2017-2019

    Patterns of incident dementia codes during the COVID-19 pandemic at an integrated healthcare system

    Journal of the American Geriatrics Society

More on COVID-19 pandemic

Effects

5

Inpatient mortality

no changein humans1OR 1.05

1 study
  1. Alzheimer's disease and related dementias were not clearly linked with inpatient mortality in humans (undergoing PCI with MCS for STEMI or CS) (OR 1.05, 95% CI 0.92-1.21).

    “Inpatient mortality was similar between groups (odds ratio (OR), 1.05; 95% confidence interval (CI), 0.92-1.21)”

    Humansundergoing PCI with MCS for STEMI or CS

    Dementia Is Associated With Higher One-Year Mortality and Worse Patient-Centered Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction and Cardiogenic Shock

    Cardiology research

Physical function

downin humans1HR 0.93

1 study
  1. Alzheimer's disease and related dementias are linked with worse physical function in humans (HR = 0.93, 95% CI:0.92, 0.94).

    “The ADRD only and delirium only groups were also less likely to improve in function (HR = 0.93, 95% CI:0.92, 0.94 and HR = 0.92, 95% CI:0.90, 0.93, respectively)”

    Humans30 daysn = 740,838

    Cognitive and functional change in skilled nursing facilities: Differences by delirium and Alzheimer's disease and related dementias

    Journal of the American Geriatrics Society

Days alive and at home

downin humans1RR 0.96

1 study
  1. Alzheimer's disease and related dementias are linked with lower days alive and at home in humans (living with ADRD vs without ADRD interaction) (additional 3.3% fewer DAAH (interaction RR = 0.96, 95% CI 0.96-0.97)).

    “This relative sex difference increased significantly when comparing those living with ADRD, with males spending an additional 3.3% fewer DAAH (interaction RR = 0.96, 95% CI 0.96-0.97).”

    Humansliving with ADRD vs without ADRD interaction12 monthsmalesn = 69,581

    Associations of sex, Alzheimer's disease and related dementias, and days alive and at home among older Medicare beneficiaries recovering from hip fracture

    Journal of the American Geriatrics Society

Opioids

downin humans1OR 0.54

1 study
  1. Alzheimer's disease and related dementias are linked with lower opioids in humans (daily interfering pain) (OR = 0.54, 95% CI: 0.47, 0.62, p < 0.001).

    “and opioids (OR = 0.54, 95% CI: 0.47, 0.62, p < 0.001)”

    Humansdaily interfering painn = 6,048

    Pain treatment and functional improvement in home health care: Relationship with dementia

    Journal of the American Geriatrics Society

More on Opioids

Analgesics

downin humans1OR 0.66

1 study
  1. Alzheimer's disease and related dementias are linked with lower analgesics in humans (daily interfering pain) (OR = 0.66, 95% CI: 0.49, 0.90, p = 0.008).

    “ADRD was related to a lower likelihood of using any analgesic (odds ratio [OR] = 0.66, 95% confidence interval [CI]: 0.49, 0.90, p = 0.008)”

    Humansdaily interfering painn = 6,048

    Pain treatment and functional improvement in home health care: Relationship with dementia

    Journal of the American Geriatrics Society

More on Analgesics

Upstream

6

GLP1R

no changein humans1HR 1.02

1 study
  1. GLP1R was not clearly linked with Alzheimer's disease and related dementias in GLP-1RA-treated adults with type 2 diabetes proxied by cis-eQTL genetic risk score (HR 1.02, 95% CI 0.81 to 1.28).

    “No association was observed for incident ADRD (HR 1.02; 95% CI 0.81 to 1.28).”

    Humansin GLP-1RA-treated adults with type 2 diabetes proxied by cis-eQTL genetic risk scoremean follow-up 3.8 ± 3.1 yearsn = 7,039

    GLP1R expression and Parkinson's disease and related disorders in GLP-1 receptor agonist-treated type 2 diabetes

    Brain : a journal of neurology

More on GLP1R

ZNF200

no changein humans1

1 study
  1. ZNF200 was not clearly linked with Alzheimer's disease and related dementias in humans after statistical refinement.

    “the association with ADRD for ZNF200 was no longer statistically significant”

    Humansafter statistical refinement

    Application of the STAAR framework in detecting rare variant associations with Alzheimer disease and related dementias: Insights and implications

    HGG advances

More on ZNF200

Heart disease

no changein humans1

1 study
  1. Heart disease was not clearly linked with Alzheimer's disease and related dementias in humans (Samoan adults) (p = 0.14).

    “Initial results from Chi‐square analysis show no association between heart disease and ADRD risk level ( p = 0.14).”

    HumansSamoan adultsn = 680

    Exploring Associations Between Heart Disease and Its Risk Factors and Alzheimer's Disease and Related Dementia In American Samoans

    AAIC 2025 abstract

More on Heart disease

Cognitive reserve

no changein humans1

1 study
  1. Cognitive reserve was not clearly linked with Alzheimer's disease and related dementias in severely frail participants.

    “but the association was not observed in severely frail participants”

    Humansin severely frail participants

    Joint association of cognitive reserve and frailty with incident Alzheimer's disease and related dementias

    Behavioural brain research

Positive cognitive screen

no changein humans1

1 study
  1. Positive cognitive screen was not clearly linked with Alzheimer's disease and related dementias in humans (one point from failing vs failed cognitive screen).

    “At 24 months, no significant differences in the rate of MCI or ADRD diagnoses were found in electronic medical records.”

    Humansone point from failing vs failed cognitive screen24 months

    DIFFERENCES IN PATIENTS WHO FAIL A COGNITIVE SCREEN IN PRIMARY CARE VS. THOSE WHO “ALMOST FAIL”

    GSA 2024 abstract

More on Positive cognitive screen

Transient ischemic attack

no changein humans1

1 study
  1. Transient ischemic attack was not clearly linked with Alzheimer's disease and related dementias in humans (matched non-Hispanic Caucasian cohort) (treatment effect coefficient = 0.403, p-value = 0.196).

    “whereas the matched Caucasians did not (treatment effect coefficient = 0.403, p -value = 0.196)”

    Humansmatched non-Hispanic Caucasian cohortn = 4,570

    Risk Factors for Progression to Alzheimer’s Disease in African Americans in a Large National Cohort

    medRxivPreprint

More on Transient ischemic attack

Associations

190

Depression

upin humans7+30% total pafHR 1.36–1.6

7 studies
  1. Depression is linked with a higher risk of Alzheimer's disease and related dementias in Veterans with TBI (RERI = 1.55, 95% CI = 0.96-2.15).

    “RERI analyses showed significant additive TBI by health condition/health behavior interactions for depression (RERI = 1.55, 95% CI = 0.96-2.15)”

    Humansin Veterans with TBI10 yearsn = 245,949

    Examining the additive risk of TBI and comorbid conditions on dementia in military veterans: a retrospective cohort study

    Alzheimer's research & therapy

  2. Depression is linked with a higher risk of Alzheimer's disease and related dementias in humans (HR = 1.36, 95% CI = 1.35-1.38).

    “Depression was associated with ADRD (hazard ratio [HR] = 1.36; 95% confidence interval [CI] = 1.35-1.38)”

    Humans

    Mid- and late-life depression increases risk of Alzheimer's disease and related dementias in veterans

    Alzheimer's & dementia (Amsterdam, Netherlands)

  3. Depression is associated with Alzheimer's disease and related dementias in humans among White beneficiaries compared to AI/AN beneficiaries.

    “depression, diabetes, and hypertension had stronger associations among White beneficiaries.”

    Humansamong White beneficiaries compared to AI/AN beneficiaries

    Alzheimer's disease and related dementias and related health conditions among American Indian and Alaska Native Medicare beneficiaries

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  4. Depression is linked with a higher risk of Alzheimer's disease and related dementias in humans (approximately 30% of total PAF).

    “depression was highest among females and White individuals (approximately 30%).”

    Humansfemales

    Population Attributable Fractions Associated with Alzheimer’s Disease Risk Factors

    GSA 2025 abstract

  5. Depression is linked with a higher risk of Alzheimer's disease and related dementias in humans (HR 1.60).

    “Associations with incident ADRD were stronger among females compared to males for higher education (Hazard Ratios (HRs): 1.33; 1.19), hypercholesterolemia (HRs:1.10; 0.98), depression (HRs: 1.60; 1.39)”

    Humansfemales

    Sex Differences in Alzheimer’s Disease Risk Factors in the Southern Community Cohort Study

    GSA 2025 abstract

  6. Depression is associated with Alzheimer's disease and related dementias in humans (hospitalized with heart failure) (24% vs 12% in neither).

    “For insomnia alone and depression alone, dementia prevalence was 21% and 24%, respectively.”

    Humanshospitalized with heart failuremalesn = 373,897

    Prevalence of Comorbid Depression and Insomnia Among Veterans Hospitalized for Heart Failure with Alzheimer Disease and Related Disorders

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  7. Depression is linked with a higher risk of Alzheimer's disease and related dementias in Caucasians (ATE = 0.1560).

    “depression significantly predisposed older Caucasian counterparts (ATE = 0.1560) to ADRD, but not in the African Americans.”

    Humansin Caucasians

    Counterfactual analysis of differential comorbidity risk factors in Alzheimer's disease and related dementias

    PLOS digital health

More on Depression

Mortality

upin humans5HR 1.54

5 studies
  1. Alzheimer's disease and related dementias are associated with mortality in humans After hip fracture surgery; adjusted multivariable analysis (HR 1.54, 95% CI 1.18–2.01).

    “mortality between 31 days and 1 year (HR 1.54, 95% CI 1.18–2.01)”

    HumansAfter hip fracture surgery; adjusted multivariable analysis31 days to 1 yearn = 3,312

    Association between Alzheimer’s disease and related dementias and postoperative outcomes after geriatric hip fracture surgery

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

  2. Alzheimer's disease and related dementias are linked with a higher risk of mortality in humans (undergoing PCI with MCS for STEMI or CS) (OR 1.41, 95% CI 1.21-1.64).

    “1-year mortality was higher among patients with ADRD (OR, 1.41; 95% CI, 1.21-1.64)”

    Humansundergoing PCI with MCS for STEMI or CS1 year

    Dementia Is Associated With Higher One-Year Mortality and Worse Patient-Centered Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction and Cardiogenic Shock

    Cardiology research

  3. Alzheimer's disease and related dementias are associated with mortality in humans (community-dwelling patients with STEMI undergoing catheterization) (36.6% vs 16.6%; adjusted difference, 10.0%).

    “Compared to those without ADRD, community-dwelling patients with ADRD had higher one-year mortality rates (36.6% vs 16.6%; adjusted difference, 10.0%)”

    Humanscommunity-dwelling patients with STEMI undergoing catheterization

    Outcomes Following Catheterization for ST-Segment Elevation Myocardial Infarction in Older Adults With Dementia

    GSA 2025 abstract

  4. Alzheimer's disease and related dementias are associated with mortality in humans (compared with beneficiaries with no evidence of ADRD).

    “These beneficiaries were older, more frail, more likely to be female, more likely to be dual-eligible, more likely to use long-term care, and more likely to die in 2019”

    Humanscompared with beneficiaries with no evidence of ADRDn = 60,000,869

    Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare

    JAMA network open

  5. Alzheimer's disease and related dementias are linked with a higher risk of mortality in humans following index ED visit (OR 1.099, 95% CI 1.091-1.107; 31.9% vs. 15.3%).

    “AD/ADRD patients had a higher risk of mortality (OR 1.099, p < 0.001, 95% CI 1.091-1.107) and high short-term mortality (31.9% within 12 months) than those without AD/ADRD (15.3% within 12 months).”

    Humansfollowing index ED visit12 months

    Emergency and post-emergency care of older adults with Alzheimer's disease/Alzheimer's disease related dementias

    Journal of the American Geriatrics Society

APOE

upin humans3mixedin humans1HR 6.52

4 studies
  1. APOE is linked with a higher risk of Alzheimer's disease and related dementias in humans with a favorable lifestyle (HR 6.52, 95% CI 2.97-14.33).

    “APOE ε4 homozygotes remained at elevated risk even with a favorable lifestyle (HR 6.52, 95% CI 2.97-14.33).”

    Humanswith a favorable lifestylemedian follow-up of 3.7 yearsn = 105,886

    A Favorable Modifiable Risk Factor Profile Mitigates Polygenic Risk for Alzheimer's Disease and Related Dementia

    medRxiv : the preprint server for health sciencesPreprint

  2. APOE is associated with Alzheimer's disease and related dementias in humans (additive interaction with CVDs) (p from 7x10 ‐8 to 0.025).

    “Both the omnibus test ( p = 5x10 ‐12 ) and the individual CVD interaction terms were significant ( p from 7x10 ‐8 to 0.025).”

    Humansadditive interaction with CVDs

    Alzheimer's Disease and Related Dementias among Aging Veterans: Examining Gene‐by‐Environment Interactions with Cardiovascular Diseases

    AAIC 2025 abstract

  3. APOE is associated with Alzheimer's disease and related dementias in humans (Cases identified using MVP-ADRD or Phe-Dementia augmented with medication-identified cases) (MVP-ADRD or medication: p = 3.6 ×10−290; Phe-Dementia or medication: p = 1.4 ×10−290).

    “The strongest APOE ε4 associations were observed in cases identified using MVP-ADRD and Phe-Dementia augmented with medication-identified cases”

    HumansCases identified using MVP-ADRD or Phe-Dementia augmented with medication-identified cases

    Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program

    Journal of Alzheimer's disease : JAD

  4. APOE is associated with Alzheimer's disease and related dementias in humans (additive gene-by-environment interaction).

    “These additive interactions indicate that ADRD prevalence associated with PTSD and TBI increased with the number of inherited APOE ε4 alleles.”

    Humansadditive gene-by-environment interaction

    Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  5. APOE is linked with a higher risk of Alzheimer's disease and related dementias in humans.

    “PTSD, TBI, and APOE ε4 showed strong main-effect associations with ADRD.”

    Humans

    Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on APOE

Stroke

upin humans3+8%

3 studies
  1. Stroke is linked with a higher risk of Alzheimer's disease and related dementias in humans (>30% of total PAF).

    “Stroke was the primary contributor for males (>30%)”

    Humansmales

    Population Attributable Fractions Associated with Alzheimer’s Disease Risk Factors

    GSA 2025 abstract

  2. Stroke is associated with Alzheimer's disease and related dementias in humans (8%).

    “Among 55,888 stroke patients in our final cohort, 8% developed ADRD in the year following their stroke.”

    Humansone yearn = 55,888

    Comparing Machine Learning and Traditional Models to Predict One‐Year Post‐Stroke Dementia Risk

    AAIC 2025 abstract

  3. Stroke is associated with Alzheimer's disease and related dementias in humans (PAF 7% (95% CI, 3 - 11%)).

    “A history of stroke was associated with a PAF for AD/ADRD of 7% (95% CI, 3 - 11%).”

    Humansn = 1,272

    Population Attributable Fraction for Cognitive Impairment in Mexican American Older Adults

    Journal of racial and ethnic health disparities

More on Stroke

Hospital length of stay

upin humans2

2 studies
  1. Alzheimer's disease and related dementias are associated with hospital length of stay in humans After hip fracture surgery; adjusted multivariable analysis (β 0.958, 95% CI 0.624–1.292).

    “ADRD patients had increased minor and major complications, ICU admissions, readmissions, 1-year mortality, and longer hospitalization (all p < 0.001).”

    HumansAfter hip fracture surgery; adjusted multivariable analysisn = 3,312

    Association between Alzheimer’s disease and related dementias and postoperative outcomes after geriatric hip fracture surgery

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

  2. Alzheimer's disease and related dementias are associated with hospital length of stay in humans (first admission for heart failure) (5.7 vs. 5.4 days).

    “Patients with ADRD demonstrated longer lengths of stays (5.7 vs. 5.4 days, p <0.005)”

    Humansfirst admission for heart failuren = 22,342

    Alzheimer's Disease and Related Dementias is Associated with Worse Clinical and Patient-centered Outcomes in Patient Admitted for Heart Failure

    Dementia and geriatric cognitive disorders

90-day readmissions

upin humans2HR 1.23

2 studies
  1. Alzheimer's disease and related dementias are associated with 90-day readmissions in humans following first admission for heart failure (HR 1.23, 95% CI 1.18-1.28).

    “Patients with ADRD hospitalized for HF demonstrate higher 1-year mortality and 90-day readmissions.”

    Humansfollowing first admission for heart failure90 daysn = 22,342

    Alzheimer's Disease and Related Dementias is Associated with Worse Clinical and Patient-centered Outcomes in Patient Admitted for Heart Failure

    Dementia and geriatric cognitive disorders

  2. Alzheimer's disease and related dementias are associated with 90-day readmissions in humans (hospitalized patients) (aOR 1.25, 95% CI 1.07-1.46).

    “Diagnosis of ADRD was associated with higher 90‐day readmissions (aOR: 1.25, 95% CI: 1.07‐1.46) and more previous hospitalizations (IRR=1.50, 95% CI: 1.35‐1.66).”

    Humanshospitalized patients

    Systematic Cognitive Impairment Screening in Hospitalized Older Patients

    AAIC 2025 abstract

Varenicline

downin humans1downin silico1HR 0.516

2 studies
  1. Varenicline is linked with a lower risk of Alzheimer's disease and related dementias in humans (receiving smoking cessation therapy relative to nicotine replacement therapy) (HR 0.516, 95% CI: 0.353-0.754).

    “Varenicline use was associated with a reduced risk of ADRD (HR 0.516, 95% CI: 0.353-0.754)”

    Humansreceiving smoking cessation therapy relative to nicotine replacement therapy

    Varenicline as a Repurposable Drug Candidate for ADRD Prevention

    medRxiv : the preprint server for health sciencesPreprint

  2. Varenicline is associated with Alzheimer's disease and related dementias in silico.

    “Our analyses yielded both suspected candidates, such as varenicline, which has supportive preclinical and early clinical evidence in ADRD, and novel candidates, such as metolazone”

    In silico

    Hybrid Value-Aware Transformer Identifies Novel and Suspected Drugs for Alzheimer’s Disease

    GSA 2025 abstract

More on Varenicline

ZeBRA

upin humans1upin silico1

2 studies
  1. ZeBRA predicts Alzheimer's disease and related dementias in humans (AUC = 0.93).

    “ZeBRA achieved AUC = 0.93 and 0.83 for predicting out to 1-year and 10-year horizons respectively”

    Humans1-year

    Bloodwork-free Early Screening for Alzheimer's Disease via Comorbid Pattern Recognition in Electronic Health Records

    Research squarePreprint

  2. ZeBRA predicts Alzheimer's disease and related dementias in silico (AUC = 0.93).

    “ZeBRA achieved AUC = 0.93 and 0.83 in the 50+ cohort for 1-year and 10-year horizons, respectively”

    In silico1-year

    Health records predicted dementia diagnoses up to a decade ahead

    NPJ digital medicine

More on ZeBRA

Insomnia

upin humans2HR 1.12

2 studies
  1. Insomnia is linked with a higher risk of Alzheimer's disease and related dementias in humans (HR 1.12, 95% CI 1.06-1.19).

    “In weighted models, insomnia alone (HR: 1.12; 95% CI: 1.06-1.19), anxiety alone (HR: 1.49; 95% CI: 1.39-1.60), and co-occurring anxiety and insomnia (HR: 1.31; 95% CI: 1.06-1.62)”

    Humans

    Combined effect of anxiety disorder and insomnia on the risk of incident ADRD diagnosis

    The journal of prevention of Alzheimer's disease

  2. Insomnia is associated with Alzheimer's disease and related dementias in humans (hospitalized with heart failure) (21% vs 12% in neither).

    “For insomnia alone and depression alone, dementia prevalence was 21% and 24%, respectively.”

    Humanshospitalized with heart failuremalesn = 373,897

    Prevalence of Comorbid Depression and Insomnia Among Veterans Hospitalized for Heart Failure with Alzheimer Disease and Related Disorders

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

More on Insomnia

Traumatic brain injury

upin humans2

2 studies
  1. Traumatic brain injury is linked with a higher risk of Alzheimer's disease and related dementias in humans (military Veterans) (12.16% vs. 4.32%).

    “Among Veterans with a TBI history (n = 7,613), 12.16% developed ADRD over 10 years of follow-up; among those without TBI (n = 238,336), 4.32% developed ADRD.”

    Humansmilitary Veterans10 yearsn = 245,949

    Examining the additive risk of TBI and comorbid conditions on dementia in military veterans: a retrospective cohort study

    Alzheimer's research & therapy

  2. Traumatic brain injury is linked with a higher risk of Alzheimer's disease and related dementias in humans.

    “PTSD, TBI, and APOE ε4 showed strong main-effect associations with ADRD.”

    Humans

    Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Traumatic brain injury

Neighborhood and built environment

downin humans2

2 studies
  1. neighborhood and built environment lowers the risk of Alzheimer's disease and related dementias in humans.

    “Higher scores on neighborhood and built environment were also associated with lower ADRD risk (HRs.69 to.70).”

    Human trialn = 2,802

    TESTING THE EFFECTS OF COGNITIVE TRAINING ON ALZHEIMER’S DISEASE AND RELATED DEMENTIAS: THE MODERATING ROLE OF SDOH

    GSA 2024 abstract

  2. Neighborhood and built environment is linked with a lower risk of Alzheimer's disease and related dementias in humans.

    “Higher scores on neighborhood and built environment were associated with lower ADRD risk.”

    Humans20-year follow-upn = 1,605

    Effects of Cognitive Training on Alzheimer's Disease and Related Dementias: The Moderating Role of Social Determinants of Health

    Journal of aging and health

More on Neighborhood and built environment

Health coaching

downin humans1

1 study
  1. Health coaching lowers the risk of Alzheimer's disease and related dementias in adherent participants (− 10.39 to − 11.45).

    “Pairwise comparisons revealed that protective score only improved in the HC group from baseline to time 2 (− 10.39 to − 11.45, p = 0.007).”

    Human trialin adherent participantsapproximately 4 months

    The effect of a digital health coaching and health education protocol on cognition in adults at-risk for Alzheimer's

    GeroScience

  2. Health coaching lowers the risk of Alzheimer's disease and related dementias in humans (when non-adherence was accounted for) (-10.39 to -11.45, p = .007).

    “the HC group saw an improvement in ADRD protective risk score (- 10.39 to - 11.45, p = .007)”

    Human trialwhen non-adherence was accounted for4 months

    The effect of a digital health coaching and health education protocol on cognition in adults at-risk for Alzheimer's

    GeroScience

More on Health coaching

Speed of processing training

downin humans1HR 0.75

1 study
  1. Speed of processing training lowers the risk of Alzheimer's disease and related dementias in humans (completed one or more booster sessions) (HR: 0.75, 95% CI: 0.59, 0.95).

    “Participants randomized to the speed-training arm who completed one or more booster sessions had a significantly lower risk of diagnosed ADRD”

    Human trialcompleted one or more booster sessions20 yearsn = 2,021

    Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study

    Alzheimer's & dementia (New York, N. Y.)

More on Speed of processing training

All 190

Trial sponsors

Funding

186 grants since 2018

National Institute on Aging$506MNational Institute of Neurological Disorders and Stroke$13.5MNational Science Foundation$1.1M

Latest

Dec 2025: 217Jan 2026: 32Feb 2026: 14Mar 2026: 24Apr 2026: 30May 2026: 18Jun 2026: 29Jul 2026: 24Aug 2026: 19Sep 2026: 33Oct 2026: 16Nov 2026: 19475 papers in 12 months
medRxiv

Brain surface area adds to dementia risk prediction

In three aging and dementia cohorts, surface area and thickness together predicted new dementia cases better than either measure alone over an average 4.3 years.In three aging and dementia cohorts, surface area and thickness together predicted new dementia cases better than either measure alone over an average 4.3 years.

Journal of Neuroinflammation

Air pollution changed brain immune cell activity in mice

A 20-week mouse experiment found that genetic background shaped how brain immune cells responded to fine-particle air pollution.A 20-week mouse experiment found that genetic background shaped how brain immune cells responded to fine-particle air pollution.

Mouse studyMechanisms
medRxiv

Genetic dementia risk linked to thinking levels and decline

An observational analysis of 11,518 US adults used 26 years of data to distinguish genetic links involving preexisting thinking ability from those involving age-related…An observational analysis of 11,518 US adults used 26 years of data to distinguish genetic links involving preexisting thinking ability from those involving age-related decline.

Preprint: cohort · 11,518 peopleAlzheimer's disease and related dementias
medRxiv

Drugs linked to dementia, falls and death in autistic adults

Exposure to medicines with anticholinergic effects was 80.0% in adults with autism alone, versus 61.3% in controls without autism or intellectual disability.Exposure to medicines with anticholinergic effects was 80.0% in adults with autism alone, versus 61.3% in controls without autism or intellectual disability.

Preprint: cohort · 61,212,067 peopleAlzheimer's disease and related dementias
bioRxiv

Brain scan charts map white matter spots across adult life

An observational analysis of 42,469 brain lesion maps from 12 adult cohorts produced reference charts comparing the amount and location of white matter changes.An observational analysis of 42,469 brain lesion maps from 12 adult cohorts produced reference charts comparing the amount and location of white matter changes.

Preprint: cross-sectional study of 42,469 peopleAI & data

See all 968 papers on Alzheimer's disease and related dementias